TECH
Bio-Techne Corp
Bio-Techne Corp historical holders
total: 7
Jensen Investment Management Bio-Techne Corp transactions over time
- Total transactions:
- 7
- New positions:
- 1
- Sold out:
- 1
- Added:
- 3
- Reduced:
- 2
- Held since:
- 2023 Q1
- Held for:
- 10 quarters
- Latest activity:
- 2025 Q3
Eric H. Schoenstein has been an institutional investor in Bio-Techne Corp (TECH) since 2023 Q1. According to 2026 Q1 report, Eric H. Schoenstein doesn't hold any shares. The fund/company first acquired TECH in 2023 Q1, initially purchasing 37,270 shares. Since the initial investment, Jensen Investment Management has made 6 more transactions in this position.
When did Eric H. Schoenstein exit their TECH position?
Eric H. Schoenstein no longer holds Bio-Techne Corp (TECH). They sold off their entire position in 2025 Q3, closing out an investment that began in 2023 Q1.
When did Eric H. Schoenstein first invest in TECH?
Eric H. Schoenstein first invested in Bio-Techne Corp (TECH) in 2023 Q1 at the reported quarter-end price of $72.43 per share, acquiring 37,270 shares in their initial purchase.
What is Eric H. Schoenstein's average cost basis for TECH?
Based on historical transaction data, Eric H. Schoenstein's estimated cost basis for Bio-Techne Corp (TECH) is approximately $74.65 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $74.65
- Weighted AVG sell price:
- $52.81
TECH transactions history by Jensen Investment Management
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q3
|
0.00%
|
0
|
$51.45
|
|
-100% (-47,450)
|
-0.03%
|
|
2025 Q1
|
0.03%
|
47,450
|
$58.63
|
$2,781,994
|
-13.35% (-7,310)
|
-0%
|
|
2024 Q3
|
0.04%
|
54,760
|
$79.93
|
$4,376,967
|
+5.19% (+2,700)
|
+0%
|
|
2023 Q4
|
0.03%
|
52,060
|
$77.16
|
$4,016,950
|
+23.95% (+10,060)
|
+0.01%
|
|
2023 Q3
|
0.02%
|
42,000
|
$68.07
|
$2,858,940
|
-3.29% (-1,430)
|
-0%
|
|
2023 Q2
|
0.03%
|
43,430
|
$81.63
|
$3,545,191
|
+16.53% (+6,160)
|
+0%
|
|
2023 Q1
|
0.02%
|
37,270
|
$72.43
|
$2,699,466
|
new
|
+0.02%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.